This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Halma PLC | 2,645.0 | 5.7% |
| Beazley PLC | 776.0 | 3.6% |
| Rolls-Royce Holdings PLC | 540.8 | 2.8% |
| B&M European Value Retail S.A. | 339.0 | 2.7% |
| Marks And Spencer Group PLC | 371.9 | 2.5% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| JD Sports Fashion PLC | 95.4 | -15.5% |
| Vodafone Group PLC | 68.9 | -3.3% |
| National Grid PLC | 964.0 | -1.9% |
| Vistry Group PLC | 624.5 | -1.5% |
| BT Group PLC | 147.7 | -1.4% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 8,149 | 0.8% | 8.9% |
| DOW JONES INDUS. AVG | 43,870 | 1.1% | 25.0% |
| DAX INDEX | 19,146 | 0.7% | 20.4% |
| NIKKEI 225 | 38,026 | -0.9% | 13.7% |
| S&P/ASX 200 INDEX | 8,323 | 0.0% | 17.7% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 70.10 | 1.96% |
| Brent Crude (ICE) | USD/bbl. | 74.40 | 2.18% |
| Gold Spot | USD/t oz. | 2,669 | 0.0% |
| Copper (Comex) | USd/lb. | 416 | -0.6% |
Click graph to enlarge
The UK 100 called to open +45 points at 8,195. The UK 100 looks set to advance again this morning, having gained during yesterday’s trading session, adding 64 points, taking the weekly gain to 69 points with todays session to go.
Yesterday Stateside The Dow Jones gained 461.88 points, or 1.06%, to finish at 43,870.35. The S&P 500 added 0.53% to close at 5,948.71. The tech-heavy Nasdaq Composite was the underperforming index, still managing to add 0.03% to end at 18,972.42.
The Dow Jones Industrial Average and the S&P rose Thursday as investors poured into cyclical stocks which are reported to be set to benefit from an accelerating US economy and rmoved out of technology shares.
GSK this morning have announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved a regulatory application to extend the indication of Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) for the prevention of RSV disease to include adults aged 50-59 at increased risk. Since September 2023, GSK’s RSV vaccine has been approved in Japan for adults aged 60 and over for the prevention of RSV disease.
Ofgem has today announced a 1.2% increase of the energy price cap for the period covering January-March 2025. The change to the price cap – which sets a maximum rate per unit and standing charge that can be billed to customers for their energy use – will rise by £21 for an average household per year or around £1.75 a month.
JD Sports downgraded by JP Morgan to Neutral from Overweight (11 Buy/ 2 Hold/ 2 Sell)
UK
Workspace Group
US
None
UK
Kingfisher
US
Zoom Video Communications
UK GfK Consumer Confidence
German Gross Domestic Product
UK Retail Sales
German Purchasing Managers Index
EU Purchasing Managers Index
UK Purchasing Managers Index
Michigan Consumer Sentiment Index
UoM 5-year Consumer Inflation Expectation
UK 100 companies going ex-dividend on 28th November 2024:
Imperial Brands
Marks and Spencer Group
United Utilities Group
3i Group
Land Securities Group
Severn Trent
UK 250 companies going ex-dividend on 28th November 2024:
Hill & Smith
Bellway
Alliance Witan
Worldwide Healthcare Trust
Fidelity Special Values
Oxford Instruments
AVI Global Trust
FirstGroup
BlackRock World Mining Trust
Ithaca Energy
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.